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surprisingly large  number  of proteins  in  eukaryotic 
ceils are  now known to contain covalently bound 
lipid.  Several cell surface proteins, the Thy-1 gly- 
coprotein (27, 55), acetylcholinesterase (14), alkaline phos- 
phatase (28), and the variant surface glycoprotein of trypano- 
somes (13), among others, are anchored to the outer cell 
surface by a complex, glycosylated phospholipid (Table  I; 
Fig. 1). A second group of proteins, which are found within 
the cell, contain the 14 carbon saturated fatty acid myristic 
acid at their amino-termini (Table I; Fig. 1). Included in this 
class is the product of the c-src proto-oncogene, p60  ~-sr~ (5); 
the catalytic subunit of the cAMP-dependent protein kinase 
(9);  the protein phosphatase calcineurin (1); a gag internal 
structural  protein  of mammalian retroviruses  (18); and a 
number of viral transforming proteins (48).  Finally, the sur- 
face glycoproteins of several enveloped viruses (45-47), the 
HLA glycoprotein (24, 50), the transforming protein of Har- 
vey sarcoma virus,  p21 r~  (6,  11,  50),  and the transferrin 
receptor (36) are part of a diverse third class of proteins that 
contain the 16 carbon saturated fatty acid palmitic acid linked 
to cysteine (Table I; Fig.  1). 
The modification of protein with lipid is not simply a bio- 
chemical curiosity.  Lipid is,  in  several  cases,  clearly re- 
quired for the binding of proteins to cellular membranes. 
Treatment ofceUs with phospholipase C, an enzyme that can 
cleave the lipid from acetylcholinesterase, alkaline phospha- 
tase, and the Thy-1 glycoprotein, releases a significant frac- 
tion of each of these proteins (14, 27, 28). Additionally, point 
mutations that prevent myristylation of p60 ~  and Pr65sa~ 
and palmitylation of p21 ~  render these proteins unable to 
bind to membranes (8, 22, 40, 57). It has become clear there- 
fore that the signals and sequences necessary for a protein 
to bind to a membrane need not be present in the primary 
structure of the protein, but can instead be acquired through 
co-translational or posttranslational modification. 
Myristylation, palmitylation, and the addition of the com- 
plex glyco-phospholipid occur by remarkably different mech- 
anisms. 
Myristylation 
In every case, myristic acid is found linked through an amide 
bond to the a-amino group of amino-terminal glycine (1, 9, 
18, 37, 49) (Fig. 1). The myristyl transferase appears to have 
an absolute specificity for both amino-terminal glycine and 
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for myristic acid. Even mutations that convert a myristylated 
glycine to alanine abolish myristylation  completely (22, 40). 
Additionally, chemical analysis of the lipid that modifies 
amino-terminal glycines yields only myristic acid (1, 9,  18, 
37, 49). These observations are borne out by studies charac- 
terizing the myristyl transferase of yeast in vitro. This en- 
zyme will myristylate  only synthetic peptides that contain an 
amino-terminal glycine and will not incorporate a fatty acid 
with a chain length of >14 methylenes (54). The question of 
whether another lipid could functionally replace myristic 
acid has not yet been addressed. 
Myristylation occurs very early during the life of a pro- 
tein. It may in fact occur co-translationally, before the syn- 
thesis of the polypeptide is complete. Drugs that inhibit pro- 
tein synthesis inhibit myristylation completely and without 
a detectable lag (7, 30, 34).  The total cessation of myristyla- 
tion after the inhibition of protein synthesis suggests that 
amino-terminal myristate does not turn over. Consistent with 
this is  the fact that the half~life of the myfistyl group in 
p60 s'~ is the same as that of the polypeptide itself (7). 
Perhaps surprisingly, a number of myristylated proteins 
are synthesized on soluble polysomes, rather than on mem- 
brane-bound polysomes. Because myristylation occurs dur- 
ing or immediately after the synthesis of a protein, the fact 
that myristylation can occur on soluble polysomes implies 
that both the myristyl  donor, which is probably myristyl CoA 
(53), and the myristyl transferase are either soluble or bound 
to polysomes. 
Myristylation requires the recognition of a specific amino 
acid sequence in the substrate protein by the myristyl trans- 
ferase.  Amino-terminal glycine is  obviously an  essential 
component of such a sequence. What else is required is not 
yet known. A sufficient signal for myristylation is apparent- 
ly present in the  14 amino-terminal residues of p60  ....  . A 
chimeric protein containing these residues appended to the 
amino-terminus of globin is myristylated (38).  Unexpect- 
edly, the amino-termini of myristylated proteins have little 
sequence homology, save for the myristylated glycine. An 
amino-terminal glycine is not in itself a sufficient signal for 
myristylation. Studies with synthetic peptides have demon- 
strated that certain penultimate residues inhibit severely the 
myristylation of peptides containing amino-terminal glycine 
(54). 
Palmitylation 
Palmitylation differs significantly from myristylation. Pal- 
mitic acid is most often found to be linked through a thioester 
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Reference 
Proteins containing a phospholipid tail 
Thy-1 glycoprotein  27,  54 
Variant surface glycoprotein of trypanosomes  13 
TAP glycoprotein  41 
Acetylcholine esterase  14 
5'-nucleotidase  26 
Alkaline phosphatase  28 
Neural cell adhesion molecule-120  17 
Plasmodium falciparum  transferrin receptor  15 
Plasmodium falciparum  p195 surface antigen  16 
Myristylated proteins 
p60  "re  5, 49 
Catalytic subunit of cAMP-dependent protein kinase  9 
Calcineurin B  1 
NADH-cytochrome b~ reductase  37 
p56  tck  32,  56 
p15  s"g of Moloney murine leukemia virus  18 
p120 g"g~j transforming protein  48 
p858asse~ transforming protein  48 
p29  Sag-r°" transforming protein  48 
Palmitylated proteins 
p21 '~  6,  11, 50 
Vesicular stomatitis virus G glycoprotein  45 
Alphavirus E2 glycoprotein  47 
Influenza virus HA glycoprotein  44 
Parainfluenza virus F glycoprotein  44 
SV40 virus large T antigen  25 
Mammalian transferrin receptor  36 
HLA B glycoprotein  24,  50 
Apolipoprotein A-I  19 
Rhodopsin  33 
Ankyrin  52 
bond to cysteine (Fig.  1).  This has been established quite 
conclusively in the case of the G  glycoprotein of vesicular 
stomatitis  virus  (43),  p21 ~  (11), the  transferrin  receptor 
(21),  and the HLA glycoprotein (24).  Early reports of pal- 
mitic acid esterified to  serine in  the viral G  protein were 
probably erroneous.  Unlike  myristic acid,  which  is  only 
found attached to amino-terminal residues, palmitic acid is 
found to modify cysteines present within the body of a poly- 
peptide.  These  residues  are  invariably  found  near  mem- 
brane-binding domains of a protein and usually on the cyto- 
plasmic face of a membrane. 
The amino acid sequence or sequences specifying palmit- 
ylation are not known. The palmitylated cysteine in p21 '~ is 
located four residues from the carboxy-terminus of the pro- 
tein and is followed by two alphatic residues. A cysteine fol- 
lowed by two aliphatic residues is also found four residues 
from the carboxy-terminus of ms proteins found in yeast (39) 
and Dictyostelium  (42),  and in several other proteins with 
partial homology with p21 '~ (10, 29). It may be that this se- 
quence is sufficient to signal palmitylation. Comparison of 
this sequence with that flanking the sites of palmitylation in 
the G glycoprotein of vesicular stomafitis virus and the trans- 
ferrin receptor reveals no obvious homology. 
The palmityl transferase has not been purified. It appears 
to show less specificity with regard to fatty acid than does 
the myristyl transferase since fatty acids other than palmitic 
acid (e.g., stearic acid) can be detected in Sindbis virus gly- 
coproteins (47). The palmityl transferase may be a cytoplas- 
mic protein because palmitic acid is usually found in regions 
of proteins  interacting with the cytoplasmic face of mem- 
branes.  The donor is likely to be palmityl CoA (3). 
In contrast to myristylation, palmitylation is a posttransla- 
tional event. The addition of palmitic acid to a number of vi- 
ral glycoproteins occurs "-,20 min after the release of the pro- 
teins  from the polysome, probably during the transport of 
the protein through the Golgi apparatus (46). Similarly, new- 
ly synthesized p21 ~  contains no palmitic acid. Only older, 
processed forms of the protein are palmitylated (50). Palmit- 
ylation can apparently occur long after the synthesis of the 
polypeptide.  The palmitylation of the  transferrin  receptor 
(35),  ankyrin  (52),  and  p21 '~  (31, and  our  unpublished 
results) many hours after the cessation of protein synthesis 
can be readily observed. Although this could reflect a slow 
rate  of palmitylation,  most  probably  it  suggests  that  the 
palmityl  moieties  in  some  proteins  undergo  fairly  rapid 
turnover. 
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Figure 1.  The linkages of the lipids bound to 
p60s% p2l"', and the Thy-I glycoprotein and 
their probable mode of interaction with the cel- 
lular plasma membrane. (*) The phosphatidyl- 
inositol  to  which  the  Thy-1 glycoprotein  is 
bound  contains  glucosamine,  galactosamine, 
mannose,  and  ethanolamine,  which  are  not 
depicted here. 
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The third type of lipid modification is the most unusual and 
unexpected. A number of cell surface glycoproteins contain 
a  large,  complex,  glycosylated phospholipid  at their  car- 
boxy-termini (Fig.  1). This lipid serves to anchor these pro- 
teins to the lipid bilayer. Incubation of intact cells with phos- 
pholipase C leads to the apparent loss of the lipid tail and the 
release of a significant fraction of these proteins in a form 
that is much less hydrophobic than is the form of the protein 
found in membranes (14, 17, 28). 
The structure of the lipid bound to these proteins has not 
been elucidated completely. As expected from its sensitivity 
to types of phospholipase C that are specific for phosphati- 
dylinositol, it contains this phospholipid as one of its com- 
ponents. In addition, ethanolamine, glucosamine, galactos- 
amine,  and mannose are present (13, 20,  55).  The variant 
surface glycoprotein protein of trypanosomes is linked to the 
glycosylated lipid through an amide bond between the termi- 
nal carboxyl group of the polypeptide and the nitrogen of 
ethanolamine (20). Ethanolamine is probably linked to the 
head group of phosphatidylinositol. The structure of the car- 
bohydrate portion of the tail is not understood. 
Although linked to the carboxy-terminus of both Thy-1 and 
variant surface glycoprotein, the glycosylated phosphatidyl- 
inositol is not in fact bound to the true carboxy-terminus of 
either protein. DNA sequence analysis shows that the genes 
for both the Thy-1 glycoprotein and the variant surface glyco- 
protein of trypanosomes encode proteins that are longer than 
the protein that is present on the surface of cells; the addi- 
tional residues being found at the carboxy-terminus of the 
primary translate (4, 51). Apparently, these proteins undergo 
proteolytic processing that removes 17-31 carboxy-terminal 
residues very soon after their synthesis (2). Only then is the 
carboxyl group to which the lipid is bound exposed. Unlike 
myristate  and  palmitate,  a  glycosylated lipid  tail  can  be 
linked to a  variety of terminal  amino  acids.  Whether the 
lipid is attached as a complete unit or in individual compo- 
nents is not yet known. 
Because the lipid tail is susceptible to digestion when in- 
tact cells are incubated with added phospholipase C, it prob- 
ably resides in the outer leaflet of the plasma membrane (Fig. 
1). Transport of the Thy-1 glycoprotein and the variant sur- 
face glycoprotein to the plasma membrane almost certainly 
is initiated by the insertion of the nascent polypeptide into 
the endoplasmic reticulum.  Work with the variant surface 
glycoprotein suggests that addition of the lipid occurs very 
soon after synthesis of the protein (2). It is reasonable to sus- 
pect therefore that the addition of the lipid tail occurs on the 
lumenal face of the membrane of the endoplasmic reticulum 
and that both the donor of the lipid and the enzymes catalyz- 
ing the reaction are found there. 
The Function of  Lipid Modification 
There is evidence that myristic acid, palmitic acid, and com- 
plex phospholipid tails can each anchor proteins to cellular 
membranes.  The function of the  myristyl groups  in  both 
p60 sr~ and Pr65  gag has been studied in the most detail.  The 
presence of the myristyl moiety is essential for the binding 
of these proteins to the  inner face of the cellular plasma 
membrane. Conservative point mutations that prevent myris- 
tylation abolish membrane binding (8, 22, 40). In the case 
of p60s~ such a mutation also almost completely inactivates 
the transforming activity of the protein without affecting its 
intrinsic protein kinase activity (8, 12, 23). The fact that both 
p60 s~  and  Pr65  gag  are  soluble  when  not  myristylated  is 
compelling evidence that myristylation can confer the ability 
to bind to membranes on an otherwise soluble protein. 
Myristylation could facilitate the binding of a protein to 
membranes simply because it is hydrophobic in character. 
This cannot explain however why a myristylated protein like 
p60 srC binds  predominantly to the  plasma  membrane.  In- 
deed, if a hydrophobic lipid is all that is required for mem- 
brane binding, it is not clear why only this nonabundant fatty 
acid is used as an amino-terminal anchor.  This raises the 
possibility that p60 srC is bound to the plasma membrane be- 
cause only this membrane contains a protein with a selective 
affinity for myristylated proteins. Myristic acid could there- 
fore facilitate membrane binding not because it is moderately 
hydrophobic but rather because it provides a signal that pro- 
motes transport of the protein to a specific location within 
the cell. 
Myristylation does not induce membrane binding in all 
cases. Cells contain a number of myri'stylated proteins that 
are  not bound tightly to cellular membranes  (7,  30,  34). 
Notable among these is the catalytic subunit of the cAMP- 
dependent protein kinase,  which is a soluble protein when 
not  associated  with  its  regulatory  subunit.  It  is  possible 
therefore that myristylation has some other function, or even 
no function, in soluble proteins. The creation and character- 
ization of a nonmyristylated catalytic subunit should help an- 
swer this question. 
Palmitylation appears to be essential  for the binding of 
p21 "a~ to cellular membranes.  Mutations  that replace cys- 
teine 186, the site of palmitylation in p21 ra', abolish palmit- 
ylation and render the protein unable to bind tightly to mem- 
branes (57). It is noteworthy that such mutations also render 
the protein inactive in cellular transformation. The simplest 
interpretation of this result may not however be correct. The 
fraction of the population of p21 r~ that contains  palmitic 
acid may be low (6) and the possibility exists that the muta- 
tion at Cys 186 has a primary effect on membrane binding, 
and prevents palmitylation only because it prevents mem- 
brane binding, rather than preventing membrane binding be- 
cause it prevents palmitylation. 
Palmitylation is apparently not essential for the correct in- 
teraction of the viral G glycoprotein with membranes. A site- 
specific mutation replacing the palmitylated cysteine has no 
measurable effect on the transport or membrane association 
of the protein (43). Generalizations as to the function of pro- 
tein palmitylation are therefore difficult to draw. Indeed, cell 
fractionation suggests that some as yet unidentified palmityl- 
ated proteins behave as  soluble proteins (our unpublished 
results) and at least one secreted protein, Apolipoprotein A-I 
is palmitylated (19). 
The fact that phospholipase C  can release proteins pos- 
sessing phospholipid tails from the surface of cells demon- 
strates directly that these lipids serve to anchor proteins to 
membranes. It is certainly not obvious however why a lipid 
with such an exotic structure is used in this apparently struc- 
tural role. The possibility exists therefore that the lipid tail 
has a function in addition to serving as an anchor. This might 
be manifest after cleavage of the protein by phospholipase C. 
Digestion by this phospholipase would yield a soluble form 
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ride, ethanolamine and inositol phosphate,  and,  separately, 
diacylglycerol.  Either could be physiologically significant. 
Diacylglycerol is the natural activator of protein kinase C and 
its production during release of a protein such as the Thy-1 
glycoprotein could allow the cell to respond to the removal 
of antigen.  Clearly much more needs to be learned about the 
function of phospholipid tails and their constituent parts. 
Another obvious and  important  question is whether the 
properties of cell  surface proteins that  are  anchored by a 
glycophospholipid tail are different from those of proteins 
that are bound to membranes by a hydrophobic polypeptide 
domain and a cytoplasmic tail. It could be that lateral mobil- 
ity of proteins with lipid tails is greater  and that an ability 
to diffuse rapidly  plays a role in the normal function of this 
class of protein.  Alternatively,  a lipid tail would allow the 
protein to be removed rapidly from the cell surface by a phos- 
pholipase C and might obviate the need for internalization 
as a means to clear the protein from the cell surface. 
How common is the modification of protein with lipid? 
Clearly it is neither extremely rare nor very common. Anal- 
ysis of cellular protein labeled biosynthetically with either 
radioactive myristic acid or palmitic acid by one-dimension- 
al SDS PAGE reveals ~50 labeled polypeptides in both cases 
(7, 30, 34). Only a few of these proteins has been identified 
and characterized  to date. Lipid modified proteins are almost 
certain  to be  exceptional,  p60  v-s~, the  myristylated  trans- 
forming protein of Rous sarcoma virus, is readily apparent 
when total cell protein from RSV-transformed  cells, labeled 
biosynthetically with radioactive myristic acid, is analyzed 
by  gel  electrophoresis.  Because  p60 src is not an abundant 
polypeptide and cannot be distinguished by one-dimensional 
gel analysis of total cellular protein, its easy detection among 
myristylated proteins suggests that none of the myristylated 
proteins are particularly  abundant. 
However, given the surprisingly large number of physio- 
logically important proteins already  known to contain lipid, 
and the fact that lipid is often essential, it can be anticipated 
that  additional  examples  of proteins  which  require  lipid 
modification for function will be found. 
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